Episode Details

Back to Episodes
two thousand twenty-six ASCO | Novogene Jianhua's new BCLtwo inhibitor Mesutoclax

two thousand twenty-six ASCO | Novogene Jianhua's new BCLtwo inhibitor Mesutoclax

Published 1 month, 3 weeks ago
Description
Smf5Yv7iSAZW7lGwgunC
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us